Curing Hep B

C2B The success in curing hep C fuels race to cure B by Larry Buhl In 2013, a revolution happened: A drug regimen was developed that could...

UFO Plan Meets IDUs

Finger on the Pulse The UFO Plan meets young IV drug users where they are by Larry Buhl Hepatitis prevention and treatment efforts depend on outreach. For...

Taking a Toll

LifeGuide Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested...

MSF Access Campaign

Without Borders A global campaign for providing low-cost HCV care rolls out by Larry Buhl Last year UNITAID funded two grants to increase access to new treatments...

Hep in the News 2016

Quick Shots a round-up of under-reported-related stories from 2016 by Larry Buhl It’s time for a 2016 desk clearing and to report some hepatitis-related stories that fell...

Direct Acting Antiretrovirals

Awareness Is Key What You Need to Know About the Side Effect Profiles of New HCV Antiretrovirals by Larry Buhl By all accounts, adding the new direct-acting...

HCV Under the Radar

It’s desk-clearing time for 2015 and time to visit some under-reported hepatitis C-related news. Hep C has been in the news quite a bit...

Smart Body Art

Do tattoos & piercings carry an increased HCV risk? by Larry Buhl In the U.S., an estimated thirty-six percent of people under thirty have tattoos, according...

Man to Man

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the...

HCV & Underreporting

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C...

LATEST POSTS

Meet Raymond Luczak, A&U’s New Fiction Editor

We are thrilled to welcome esteemed writer Raymond Luczak to our team as fiction editor. Raymond has been with the magazine from issue one—no...

Alan Ramírez: Advocate